CENP-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer

Breast Cancer Research, 05/07/2012

Centromere protein A (CENP–A) was a significant independent prognostic marker for patients with ER–positive breast cancer not treated with systemic therapy but had limited predictive value in tamoxifen treated patients and was not predictive of response to neoadjuvant chemotherapy.

Print Article Summary Cat 2 CME Report